Q3 2025 Holdings
Filed 2025-11-14 | 36 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $207.0M | 17,878,594 | 14.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $165.6M | 1,950,000 | 11.4% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $118.5M | 8,325,000 | 8.2% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $94.8M | 3,192,521 | 6.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $72.7M | 1,400,000 | 5.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $65.0M | 4,010,000 | 4.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $64.3M | 1,059,331 | 4.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $63.6M | 775,000 | 4.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $61.9M | 430,000 | 4.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $61.9M | 2,175,000 | 4.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $53.0M | 1,000,000 | 3.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $46.7M | 1,925,000 | 3.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $34.0M | 1,363,200 | 2.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $30.0M | 2,375,000 | 2.1% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $27.4M | 1,916,439 | 1.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $25.2M | 625,000 | 1.7% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $22.3M | 465,000 | 1.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $21.4M | 1,225,000 | 1.5% |
| Metsera Inc | COM | 59267L107 | $20.9M | 400,000 | 1.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $20.8M | 850,000 | 1.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $17.8M | 300,000 | 1.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $16.7M | 400,000 | 1.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $15.9M | 2,323,595 | 1.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $14.6M | 775,000 | 1.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $14.3M | 1,994,173 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $13.1M | 300,000 | 0.9% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $12.6M | 2,140,605 | 0.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $12.1M | 100,000 | 0.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $11.7M | 5,000,000 | 0.8% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $10.3M | 533,340 | 0.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $8.6M | 2,147,396 | 0.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $7.2M | 3,570,872 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $6.8M | 500,000 | 0.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.3M | 175,000 | 0.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.1M | 200,000 | 0.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $150.1K | 10,000 | 0.0% |